Connect Biopharma Holdings Ltd
CNTB
NASDAQ
Biotechnology
$2.55
USD
+0.01 (+0.39%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $159.93M
Volume 209.8K
Revenue
$2.95M
TTM
+50.3%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-68.99M
TTM
-53.5%
YoY
Operating Cash Flow
$-60.58M
TTM
-60.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.2 | 2.8 |
YoY Growth | -99.8% | -98.7% | -100.0% | — | +5666.7% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.2 | 2.8 |
Selling, General & Administrative | 4.7 | 6.6 | 4.2 | 4.7 | 4.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 13.5 | 17.7 | 15.5 | 19.8 | 20.4 |
Operating Income | -13.4 | -17.7 | -15.5 | -19.6 | -17.6 |
EBITDA | -13.3 | -17.5 | -15.3 | -19.4 | -17.4 |
Other Income / Expense | -0.0 | -0.0 | 0.1 | -0.0 | 0.1 |
Total Other Income / Expense | 0.6 | 0.5 | 0.4 | 0.3 | 0.4 |
Income Before Income Taxes | -12.8 | -17.1 | -15.1 | -19.4 | -17.2 |
Income Taxes | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 |
Net Income | -12.9 | -17.2 | -15.1 | -19.4 | -17.3 |
Consolidated Net Income / Loss | -12.9 | -17.2 | -15.1 | -19.4 | -17.3 |
Net Income Attributable to Common Shareholders | -12.9 | -17.1 | -15.5 | -19.4 | -17.3 |
Basic EPS | -$0.23 | -$0.31 | -$0.28 | -$0.34 | -$0.27 |
Diluted EPS | -$0.23 | -$0.31 | -$0.28 | -$0.34 | -$0.27 |
Basic Shares Outstanding | 55.5M | 55.7M | 56.1M | 56.5M | 62.9M |
Diluted Shares Outstanding | 55.5M | 55.7M | 56.1M | 56.5M | 62.9M |